Form 4: Director Chorman Receives Standex Restricted Stock Grant

Standex International Director Thomas E. Chorman was granted 639 shares of common stock as restricted stock, vesting in three years.

Summary

• Thomas E. Chorman, a Director of Standex International Corporation (SXI), acquired 639 shares of common stock.
• The acquisition was a grant of restricted stock, with a transaction price of $0 per share.
• The restricted stock grant was made pursuant to the Company's 2018 Omnibus Incentive Plan.
• These granted shares will vest three years after the grant date.
• Following this transaction, Thomas E. Chorman beneficially owns a total of 14,229 shares of common stock.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a director is a positive event as it aligns management's interests with shareholders, though it's a routine compensation matter and not indicative of significant operational changes.

Positives

• The grant of restricted stock to a director aligns management's long-term interests with those of shareholders, encouraging sustained performance.

Future Outlook

The granted restricted stock is scheduled to vest three years from the grant date, indicating a future alignment of director compensation with long-term company performance.

Industry Context

Restricted stock grants are a common form of executive and director compensation across various industries, designed to incentivize long-term commitment and align interests with shareholder value.

Comparison to Industry Standards

• Granting restricted stock to directors is a standard practice in corporate governance, comparable to compensation structures seen in many publicly traded companies across the S&P 500, such as Apple Inc. (AAPL) or Microsoft Corp. (MSFT), which utilize similar equity incentive plans to retain and motivate key personnel.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant aligns the director's financial interests with long-term shareholder value creation.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• The restricted stock granted to Thomas E. Chorman will vest three years from the grant date of October 21, 2025.

Key Dates

Recommendation

The filing reports a routine restricted stock grant to a director, which is a standard component of executive compensation. This event, while positive for aligning interests, does not provide new fundamental information to alter an investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

Standex International, SXI, Thomas E. Chorman, Restricted Stock, Stock Grant, Form 4, Insider Transaction, Director Compensation, Omnibus Incentive Plan